Identification of a 3-Gene Model as Prognostic Biomarker in Patients With Gastric Cancer

OBJECTIVE: Although the incidence of gastric cancer (GC) is decreasing, GC remains one of the leading cancers in the world. Surgical resection, radiotherapy, chemotherapy, and neoadjuvant therapy have advanced, but patients still face the risk of recurrence and poor prognosis. This study provides ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Siming, Zheng, Tianjiao, Yan, Juan, Ma, Jinmin, Lin, Cong, Dong, Shichen, Wei, Chen, Li, Tong, Zhang, Xiaoyin, Li, Guibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329618/
https://www.ncbi.nlm.nih.gov/pubmed/35912206
http://dx.doi.org/10.3389/fonc.2022.930586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329618/
https://www.ncbi.nlm.nih.gov/pubmed/35912206
http://dx.doi.org/10.3389/fonc.2022.930586

Ejemplares similares